Pharmaceutical formulation
Patent 5874063 Issued on February 23, 1999. Estimated Expiration Date: 
February 26, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 26, 2016. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesCompositions and process of treatment -Aminomethylbenzyl alcohol derivatives Composition for treating asthma 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity Aerosol carriers Patent #: 5376386 InventorsAssigneeApplicationNo. 606655 filed on 02/26/1996US Classes:424/45, Organic pressurized fluid424/46, Powder or dust containing424/489Particulate form (e.g., powders, granules, beads, microcapsules, and pellets)ExaminersPrimary: Criares, Theodore J.Attorney, Agent or FirmForeign Patent References
International ClassesA61L 009/04A61K 009/14 Foreign Application Priority Data1991-04-11 SEAbstractThere are described finely divided particles of a pharmaceutical substance, wherein the substance when submitted to water vapor gives off heat of less than 1.2 Joules per gram, processes for their production and pharmaceutical formulations containing them.Other References
| |
